Pharmacovigilance

Astrapharm Company guarantees the quality, efficiency and safety of the products. To do this, we regularly monitor our customers’ reviews and collect information from pharmacists, consulting physicians, and consumers who deal with our products. Astrapharm pharmacovigilance meets the requirements of the Order of the Ministry of Health of Ukraine dated 26.12.2006 No. 898 “On Approval of the Procedure for Supervision over Adverse Drug Reactions of Medicinal Products Permitted for Medical Use”. https://www.inwatches.co.uk/

Dear healthcare professionals and consumers of medicines!

If you have information about side effects or lack of efficacy of medicines manufactured by Astrapharm, we suggest you fill out the form below or report the information in any way convenient for you.

1. Message information

Date of filling the message*

Date of first received case information*

Case type*

Serious AR case notification?
YesNo

MESSAGE SOURCE INFORMATION

Last Name

First Name

Patronymic

Country*

Organization*

Region

City/town

Street, house no

E-mail

Phone/fax:

Message source qualification*

SENDER DATA

Last Name

First Name

Patronymic

Country*

Organization*

Region

City/town

Street, house no

E-mail

Phone/fax:

Sender*

Are there any additional documents?
NoYes

Comment

2. Patient information

Date of Birth*

Age*

Patient initials*

No. of case history

Outpatient card number

Sex
MaleFemaleUnknown

Gestational age

Treatment

Information in the event of patient death

Date of death

Cause of death

Whether an autopsy was performed?
YesNoUnknown

Comment

3. Data from laboratory and instrumental studies regarding adverse reactions

Results of laboratory and instrumental studies

Are there any additional documents?
YesNoUnknown

Comment

4. Other medical information

Important medical information

Diagnosis	Accompanying illnesses	Allergy	Pregnancy

Add

Disease

The date of the beginning

Continues
YesNoUnknown

Medicines

Start date of therapy

Expiration date

Are there any additional documents?
NoYes

5. Adverse reactions/lack of effectiveness

Description of the case of an adverse reaction/indication of lack of effectiveness (Each manifestation of an adverse reaction and remedy should be described separately)

6. Medicines

Suspected drugs

Medicines	Release form	Manufacturer, name	Indications for appointment	Input method	Single dose	Frequency rate of acceptance

Add

Initiation of therapy

End of therapy

The therapy continues?
NoYes

The drug is prescribed by a doctor
YesNoUnknown

Correction tools

Re-prescribing a suspect drug?

Concomitant medications?

Medicine	Release form	Manufacturer, name	Indications for appointment	Input method	Single dose	Frequency rate of acceptance

Add

Initiation of therapy

End of therapy

The therapy continues
YesNo

Are there any additional documents?
YesNo

1. Message information

Date of filling the message*

Date of first received case information*

Case type*

Serious AR case notification?
YesNo

MESSAGE SOURCE INFORMATION

Last Name

First Name

Patronymic

Country*

Organization*

Region

City/town

Street, house no

E-mail

Phone/fax:

Message source qualification*

SENDER DATA

Last Name

First Name

Patronymic

Country*

Organization*

Region

City/town

Street, house no

E-mail

Phone/fax:

Sender*

Are there any additional documents?
NoYes

Comment

2. Patient information

Date of Birth*

Age*

Patient initials*

No. of case history

Outpatient card number

Sex
MaleFemaleUnknown

Gestational age

Treatment

3. Data from laboratory and instrumental studies regarding adverse reactions

Results of laboratory and instrumental studies

Are there any additional documents?
YesNoUnknown

Comment

4. Other medical information

Diagnosis:

Date of onset of the disease:

Continues:
YesNoUnknown

Allergy:
YesNoUnknown

Pregnancy:
YesNo

Medicine:

Date of initiation of therapy with this drug:

End date of therapy with this drug:

5. Adverse reactions/lack of effectiveness

Description of the case of an adverse reaction/indication of lack of effectiveness (Each manifestation of an adverse reaction and remedy should be described separately)

Description of adverse reaction/indication of lack of effectiveness

Onset of adverse reaction/lack of effectiveness:

End of adverse reaction:

Add

6. Medicines

Suspect drug

Medicine	Suspect drug	Indications for appointment	Input method	Single dose	Frequency rate of acceptance

Add

Initiation of therapy

End of therapy

Is the therapy ongoing?
NoYes

The drug is prescribed by a doctor
YesNoUnknown

Correction tools

Reassigning Suspect drug?

Related drugs

Medicine	Release form	Manufacturer, name	Indications for appointment	Input method	Single dose	Frequency rate of acceptance

Add

Initiation of therapy

End of therapy

The therapy continues
YesNo

Are there any additional documents?
YesNo

In our team, real professionals are responsible for pharmacovigilance.

You can contact the pharmacovigilance department at:

E-mail: astrapharmsur@ukr.net

or by calling: +38 (093) 544 95 42

We will maintain your privacy. Any personal information you provide to us about the use of our drugs will not be disclosed without your consent. Exceptions are cases established by law.